Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Early balding men may have insulin resistance, but lifestyle changes can help.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Obesity and lifestyle strongly affect heart aging.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Young women with PCOS without additional risk factors may have normal heart function.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Finasteride causes harmful organ changes in female mice.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Glycoconjugates help heal hair follicles during skin repair.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.